Increased Expression of Vascular Endothelial Growth Factor in Kidney Leads to Progressive Impairment of Glomerular Functions
Open Access
- 1 July 2007
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American Society of Nephrology
- Vol. 18 (7), 2094-2104
- https://doi.org/10.1681/asn.2006010075
Abstract
Vascular endothelial growth factor (VEGF) is an important mediator in maintaining normal kidney functions. In addition, several lines of evidence suggest that upregulation of VEGF in glomeruli may be associated with or cause renal dysfunction such as diabetic nephropathy. For elucidation of the pathologic consequences of high levels of VEGF in glomeruli, transgenic (Tg) rabbits that express human VEGF165 isoform in both kidney and liver under the control of the human α-1-antitrypsin promoter were generated and characterized. With the use of heterozygous Tg rabbits and their littermates aged 8 to 55 wk, renal functions and structures were investigated. Compared with control rabbits, Tg rabbits exhibited progressive proteinuria with increased GFR at the early stage and decreased GFR at the later stage. Histologic examinations revealed that Tg rabbit kidneys were characterized by considerable glomerular hypertrophy as a result of increased proliferation of both glomerular capillaries and mesangial cells accompanied by prominent podocyte hypertrophy. With increasing age starting from 20 wk, Tg rabbit kidneys showed prominent formation of microaneurysms and capillary proliferation at the vascular pole area. At a later stage (55 wk), many glomeruli showed sclerosis and tuft collapse with the formation of glomerular cysts on a background of tubular atrophy and interstitial fibrosis. This study provides the first evidence that increased expression of VEGF in glomeruli directly causes the glomerular hypertrophy that is associated with proteinuria, suggesting that VEGF exerts multiple effects on the glomerular pathophysiologic processes.Keywords
This publication has 35 references indexed in Scilit:
- Macrophage Metalloelastase Accelerates the Progression of Atherosclerosis in Transgenic RabbitsCirculation, 2006
- Transgenic rabbits with increased VEGF expression develop hemangiomas in the liver: a new model for Kasabach–Merritt syndromeLaboratory Investigation, 2005
- C-Reactive Protein in Atherosclerotic LesionsThe American Journal of Pathology, 2005
- Angiotensin II stimulates α3(IV) collagen production in mouse podocytes via TGF-β and VEGF signalling: implications for diabetic glomerulopathyNephrology Dialysis Transplantation, 2005
- Vascular endothelial growth factor (VEGF) and soluble VEGF receptor FLT-1 in diabetic nephropathyKidney International, 2005
- Protective effect of vascular endothelial growth factor/vascular permeability factor 165 and 121 on glomerular endothelial cell injury in the ratLaboratory Investigation, 2004
- High Glucose Induced VEGF Expression via PKC and ERK in Glomerular PodocytesBiochemical and Biophysical Research Communications, 2002
- VEGF165 mediates glomerular endothelial repairJCI Insight, 1999
- Vascular endothelial growth factor is an essential molecule for mouse kidney development: glomerulogenesis and nephrogenesis.JCI Insight, 1997
- Transgenic mice expressing high levels of soluble TNF‐R1 fusion protein are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Listeria monocytogenes and Leishmania major infectionsEuropean Journal of Immunology, 1995